| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
Trial completed |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
date change Completion moved earlier: 2026-10-03 -> 2026-03-31 |
| 2026-05-23 | NCT01190930 Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With… | Lymphoblastic Lymphoma, Childhood | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT03914625 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic… | Recurrent B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02112916 | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With… | Adult T Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07072585 | Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With… | Stage II T Lymphoblastic Leukemia/Lymphoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06390319 | Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06533748 | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06124157 | A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT06317662 | Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT07636564 | Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Acute Leukemia of Ambiguous Lineage | Not Yet Recruiting |
| Phase 1 | |||
| NCT03571321 | Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute… | Acute Lymphoblastic Leukemia | Recruiting |